Reuters logo
BRIEF-GSK, Theravance submit regulatory application for UMEC/VI in the U.S.
December 18, 2012 / 12:10 PM / 5 years ago

BRIEF-GSK, Theravance submit regulatory application for UMEC/VI in the U.S.

LONDON, Dec 18 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for umec/vi (lama/laba) in

the US * Regulatory filings for umec/vi are planned in the EU imminently and in other

countries during the course of 2013

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below